Werfen: FDA 510(k) clearances across all its applicant names

FDA lists 523 510(k) clearances, 0 PMA and 3 De Novo decisions across the 8 applicant names Caduvo groups under Werfen, first 1976, latest 2026. Median 510(k) review time across these names: 73 days. Since 2017 the median was 119 days, against 173 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

510(k) clearances per year

YearClearancesMedian review days
20124237
20135225
20145169
201510257
201612260
20178216
2018373
2019658
20204158
20215518
20223299
20239251
20242418
2025259
2026330

The 8 FDA applicant names in this group

Applicant name510(k) clearancesPMADe NovoYears
Instrumentation Laboratory CO323011976–2023
Inova Diagnostics, Inc.136021988–2026
International Technidyne Corp.48001983–2013
Instrumentation Laboratory (IL) Co.5002024–2026
Accriva Diagnostics, Inc.3002019–2023
Immucor, Inc.3001991–2021
Instrumentation Laboratory Company3002023–2023
Immucor Gti Diagnostics, Inc.2002020–2020

Review time against the same product codes

Since 2017, 510(k)s cleared under these names took a median 119 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 173 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
LLLExtractable Antinuclear Antibody, Antigen And Control3737
GGPTest, Qualitative And Quantitative Factor Deficiency2828
JPASystem, Multipurpose For In Vitro Coagulation Studies2323
GJSTest, Time, Prothrombin1919
CHLElectrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph1616
GGNPlasma, Coagulation Control1212
MVMAutoantibodies, Endomysial(Tissue Transglutaminase)1212
GKPInstrument, Coagulation, Automated1111
DAPFibrinogen And Fibrin Split Products, Antigen, Antiserum, Control1010
GFOActivated Partial Thromboplastin1010

Plus 176 more product codes.

Review panels

Most recent Werfen 510(k) clearances

510(k)DeviceApplicant nameProduct codeDecision dateReview days
K260551HemosIL Factor V Leiden (APC Resistance V)Instrumentation Laboratory (IL) Co.GGW2026-03-2030
K243979Aptiva APS IgA ReagentInova Diagnostics, Inc.MSV2026-02-06410
K253957HemosIL Silica Clotting TimeInstrumentation Laboratory (IL) Co.GFO2026-01-0930
K251968HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XLInstrumentation Laboratory (IL) Co.KQJ2025-07-2428
K243374HemosIL CL HIT-IgG(PF4-H)Instrumentation Laboratory (IL) Co.LCO2025-01-2890
K223093Aptiva APS IgG Reagent; Aptiva APS IgM ReagentInova Diagnostics, Inc.MID2024-12-17809
K242127ACL TOP Family 50 Series (ACL TOP 750; ACL TOP 750 CTS; ACL TOP 750 LAS; ACL TOP 550 CTS; ACL TOP 350 CTS)Instrumentation Laboratory (IL) Co.GKP2024-08-1628
K233790ACL TOP 970 CLInstrumentation Laboratory COJPA2023-12-2931
K230852HemosIL Chromogenic Factor IXInstrumentation Laboratory CompanyGGP2023-12-13260
K221359ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgMInstrumentation Laboratory COJPA2023-09-29506

513 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN190032De NovoAnti-Factor Xa Activity Test System, Apixaban2020-09-17
DEN140039De NovoAutomated Indirect Immunofluorescence Microscope And Software-Assisted System For Clinical Use2015-04-09
DEN000007De NovoAntibodies, Saccharomyces Cerevisiae (S.Cerevisiae)2000-08-16

Recalls

132 product recalls in 60 recall events under these names; 49 initiated in the last five years.

Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

How this group is built

Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

Werfen owns Instrumentation Laboratory (since 1991), Inova Diagnostics (2008), Accriva (formerly ITC, 2017) and Immucor (completed March 15, 2023). Includes filings made before each acquisition.

Sources

Frequently asked questions

How many FDA 510(k) clearances are listed across Werfen's applicant names?

FDA lists 523 510(k) clearances, 0 PMA and 3 De Novo decisions across the 8 applicant names Caduvo groups under Werfen, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.

Which FDA applicant names does Werfen file under?

The names with the most 510(k) clearances in this group are Instrumentation Laboratory CO (323); Inova Diagnostics, Inc. (136); International Technidyne Corp. (48); Instrumentation Laboratory (IL) Co. (5); Accriva Diagnostics, Inc. (3). The full list of 8 names is on this page.

How long does FDA take to clear Werfen 510(k)s?

The median time from FDA receipt to decision across 510(k)s cleared under these names is 73 days. Since 2017 the median was 119 days, against 173 days for all cleared 510(k)s in the same product codes.

Does the Werfen count include acquired companies?

Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls). Applicant names are matched exactly, with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this grouping or data.

All parent companies · FDA device companies by applicant name · FDA product code lookup